Managing Miosis and Postsurgical Pain in Cataract Surgery

0.50 CME
30 MINS
$0 FEE
SAVE
ophthalmology

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by an educational grant from Omeros Corporation.


Activity Description

Intraoperative miosis is a common problem that increases the risk of complications such as posterior capsule rupture, vitreous loss, corneal edema, and cystoid macular edema during cataract surgery. Such complications can induce negative effects on key outcomes, including recovery of functional vision, the need for reoperation, and the occurrence of ocular pain. Furthermore, postsurgical ocular pain and inflammation cause discomfort, reduced quality of life, and decreased patient satisfaction with their procedure. Several therapeutic and surgical options are currently available, including intraoperative intracameral therapy, which has been shown to reduce the risk of miosis, postoperative pain and inflammation, and has the potential to enhance patient satisfaction and postoperative outcomes. Within this live educational symposium, experts in the field will evaluate new evidence for the safety and efficacy of therapeutics that prevent miosis during cataract surgery, as well as assess new advances that reduce pain and inflammation in patients after cataract surgery.


Target Audience

The intended audience for the activity is ophthalmologists and other health care professionals involved in the management of patients undergoing cataract surgery.


Learning Objective(s)

Upon successful completion of this activity, participants should be better able to:

  • Evaluate new evidence about the safety and efficacy of therapeutics for the prevention of miosis during cataract surgery.
  • Assess new advances that reduce postoperative pain and inflammation in patients undergoing cataract surgery.

Moderator

Eric D. Donnenfeld, MD
Ophthalmic Consultants of Long Island
Clinical Professor of Ophthalmology
New York University
Trustee, Dartmouth Medical School
New York, NY


Faculty

Lisa M. Nijm, MD, JD
Warrenville EyeCare and LASIK
Founder and Medical Director
Cornea, Cataract, and Refractive Surgery 
Assistant Clinical Professor of Ophthalmology 
University of Illinois Eye and Ear Infirmary 
Department of Ophthalmology and Visual Science 
Chicago, IL


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, March 17, 2020, through March 16, 2021.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Faculty and Moderator report the following relationship(s)

Eric D. Donnenfeld, MD
Consulting Fee: AcuFocus, Alcon, Allegro, Allergan, Avedro, Bausch + Lomb, BlephEx, BVI, CRST, CorneaGen, Dompè, Elenza, EyePoint, Foresight, Glaukos, Icon Bioscience, J&J Vision, Kala, Katena, LacriPen, LensGen, Mati Pharmaceuticals, MDbackline, Merck, Mimetogen, Nanowafer, NovaBay, Novaliq, Novartis, Ocular Innovations, Oculis, Odyssey, Omega Ophthalmics, Omeros, Orasis, Oyster Point, Pfizer, PogoTec, Physician Recommended Nutriceuticals, ReTear, RPS, Shire, Strathspey Crown, Sun, Surface, TearLab, TLC Laser Centers, TrueVision, Veracity, Versant Ventures, Zeiss 
Speakers Bureau: AcuFocus, Alcon, Allegro, Allergan, Avedro, Bausch + Lomb, BlephEx, BVI, CRST, CorneaGen, Dompè, Elenza, EyePoint, Foresight, Glaukos, Icon Bioscience, J&J Vision, Kala, Katena, LacriPen, LensGen, Mati Pharmaceuticals, MDbackline, Merck, Mimetogen, Nanowafer, NovaBay, Novaliq, Novartis, Ocular Innovations, Oculis, Odyssey, Omega Ophthalmics, Omeros, Orasis, Oyster Point, Pfizer, PogoTec, Physician Recommended Nutriceuticals, ReTear, RPS, Shire, Strathspey Crown, Sun, Surface, TearLab, TLC Laser Centers, TrueVision, Veracity, Versant Ventures, Zeiss 
Ownership Interest: AcuFocus, Avedro, CorneaGen, Elenza, EyePoint, Glaukos, LacriPen, LensGen, Mati Pharmaceuticals, MDbackline, Mimetogen, NovaBay, OcuHub, Ocular Innovations, Oculis, Omeros, Orasis, PogoTec, ReTear, RPS, Sarcode, Strathspey Crown, Surface, TearLab, TrueVision, Veracity, Versant Ventures, Visionary Ventures

Lisa M. Nijm, MD, JD
Consulting Fee: Akorn, Alcon, Allergan, Bruder, EyePoint, J&J Vision, Kala, Novartis, Ocular Therapeutix, Omeros, Zeiss
Speakers Bureau: Kala, Omeros
Medical Advisory Board: LacriScience

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com